BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 12/06/2012

FDA Releases Draft Guidance on Transferring Clinical Investigation Oversight

The FDA has released a draft guidance document outlining considerations for transferring clinical investigation oversight from one Institutional Review Board (IRB) to another, addressing regulatory responsibilities and procedures for clinical investigators and sponsors.

Source: Federal Register — Food and Drug AdministrationOpen original release →